DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Coleman RL, Oza AM, Lorusso D. et al.
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet 2017;
390: 1949-1961
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.